A copy number variation in human NCF1 and its pseudogenes

BMC Genetics

Volumn 11, Issue , 2010, Pages

  Brunson, Tiffany ^a   Wang, Qingwei ^a   Chambers, Isfahan ^a   Song, Qing ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NEUTROPHIL CYTOSOLIC FACTOR 1; NEUTROPHIL CYTOSOLIC FACTOR 1B; NEUTROPHIL CYTOSOLIC FACTOR 1C; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALTERNATIVE RNA SPLICING; ARTICLE; CAUCASIAN; CELL DIFFERENTIATION; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE LOCATION; HISPANIC; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; NUCLEOTIDE SEQUENCE; PEDIGREE; PSEUDOGENE; STOP CODON; CELL LINE; DNA SEQUENCE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; INHERITANCE; MOLECULAR CLONING;

AFRICAN AMERICANS; ALTERNATIVE SPLICING; CELL LINE; CLONING, MOLECULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INHERITANCE PATTERNS; MEXICAN AMERICANS; NADPH OXIDASE; PSEUDOGENES; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 77649280161     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-11-13     Document Type: Article

References (48)

1. Korbel JO, Kim PM, Chen X, Urban AE, Weissman S, Snyder M, Gerstein MB. The current excitement about copy-number variation: how it relates to gene duplications and protein families. Curr Opin Struct Biol 2008, 18(3):366-374. 10.1016/j.sbi.2008.02.005, 2577873, 18511261.
2. Cooper GM, Nickerson DA, Eichler EE. Mutational and selective effects on copy-number variants in the human genome. Nat Genet 2007, 39(7 Suppl):S22-29. 10.1038/ng2054, 17597777.
3. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006, 7(2):85-97. 10.1038/nrg1767, 16418744.
4. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, Simons JF, Kim PM, Palejev D, Carriero NJ, Du L, et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007, 318(5849):420-426. 10.1126/science.1149504, 2674581, 17901297.
5. Nguyen DQ, Webber C, Ponting CP. Bias of selection on human copy-number variants. PLoS Genet 2006, 2(2):e20. 10.1371/journal.pgen.0020020, 1366494,1366494, 16482228.
6. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, et al. Global variation in copy number in the human genome. Nature 2006, 444(7118):444-454. 10.1038/nature05329, 2669898, 17122850.
7. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi M, et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305(5683):525-528. 10.1126/science.1098918, 15273396.
8. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, Pertz LM, Haugen E, Hayden H, Albertson D, Pinkel D, et al. Fine-scale structural variation of the human genome. Nat Genet 2005, 37(7):727-732. 10.1038/ng1562, 15895083.
9. Volpp BD, Nauseef WM, Donelson JE, Moser DR, Clark RA. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci USA 1989, 86(18):7195-7199. 10.1073/pnas.86.18.7195, 298023, 2550933.
10. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 2009, 41(4):217-225. 10.3858/emm.2009.41.4.058, 2679237, 19372727.
11. Rada B, Leto TL. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 2008, 15:164-187. full_text, 2776633, 18511861.
12. Casimir CM, Bu-Ghanim HN, Rodaway AR, Bentley DL, Rowe P, Segal AW. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci USA 1991, 88(7):2753-2757. 10.1073/pnas.88.7.2753, 51317, 2011585.
13. Noack D, Rae J, Cross AR, Ellis BA, Newburger PE, Curnutte JT, Heyworth PG. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. Blood 2001, 97(1):305-311. 10.1182/blood.V97.1.305, 11133775.
14. Barry-Lane PA, Patterson C, Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001, 108(10):1513-1522. 209414, 11714743.
15. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000, 86(5):494-501.
16. Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J, Hoyt RF, Holland SM, Finkel T. Vascular effects following homozygous disruption of p47(phox): An essential component of NADPH oxidase. Circulation 2000, 101(11):1234-1236.
17. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2000, 20(6):1529-1535.
18. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40(4):511-515. 10.1161/01.HYP.0000032100.23772.98, 12364355.
19. Thomas M, Gavrila D, McCormick ML, Miller FJ, Daugherty A, Cassis LA, Dellsperger KC, Weintraub NL. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 2006, 114(5):404-413. 10.1161/CIRCULATIONAHA.105.607168, 16864727.
20. Francke U, Hsieh CL, Foellmer BE, Lomax KJ, Malech HL, Leto TL. Genes for two autosomal recessive forms of chronic granulomatous disease assigned to 1q25 (NCF2) and 7q11.23 (NCF1). Am J Hum Genet 1990, 47(3):483-492. 1683885, 2393022.
21. Baumer A, Dutly F, Balmer D, Riegel M, Tukel T, Krajewska-Walasek M, Schinzel AA. High level of unequal meiotic crossovers at the origin of the 22q11. 2 and 7q11.23 deletions. Hum Mol Genet 1998, 7(5):887-894. 10.1093/hmg/7.5.887, 9536094.
22. Del Campo M, Antonell A, Magano LF, Munoz FJ, Flores R, Bayes M, Perez Jurado LA. Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. Am J Hum Genet 2006, 78(4):533-542. 10.1086/501073, 1424678, 16532385.
23. Gorlach A, Lee PL, Roesler J, Hopkins PJ, Christensen B, Green ED, Chanock SJ, Curnutte JT. A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease. J Clin Invest 1997, 100(8):1907-1918. 10.1172/JCI119721, 508379, 9329953.
24. Roesler J, Curnutte JT, Rae J, Barrett D, Patino P, Chanock SJ, Goerlach A. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. Blood 2000, 95(6):2150-2156.
25. Heyworth PG, Noack D, Cross AR. Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection. Blood 2002, 100(5):1845-1851. 10.1182/blood-2002-03-0861, 12176908.
26. Gruber JD, Colligan PB, Wolford JK. Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing. Hum Genet 2002, 110(5):395-401. 10.1007/s00439-002-0722-6, 12073008.
27. Jeon JP, Shim SM, Nam HY, Baik SY, Kim JW, Han BG. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines. Cancer Genet Cytogenet 2007, 173(2):122-130. 10.1016/j.cancergencyto.2006.10.010, 17321327.
28. Boyle JJ. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 2005, 3(1):63-68. 10.2174/1570161052773861, 15638783.
29. Zheng D, Gerstein MB. The ambiguous boundary between genes and pseudogenes: the dead rise up, or do they?. Trends Genet 2007, 23(5):219-224. 10.1016/j.tig.2007.03.003, 17382428.
30. Balakirev ES, Ayala FJ. Pseudogenes: are they "junk" or functional DNA?. Annu Rev Genet 2003, 37:123-151. 10.1146/annurev.genet.37.040103.103949, 14616058.
31. Mighell AJ, Smith NR, Robinson PA, Markham AF. Vertebrate pseudogenes. FEBS Lett 2000, 468(2-3):109-114. 10.1016/S0014-5793(00)01199-6, 10692568.
32. Vanin EF. Processed pseudogenes: characteristics and evolution. Annu Rev Genet 1985, 19:253-272. 10.1146/annurev.ge.19.120185.001345, 3909943.
33. Torrents D, Suyama M, Zdobnov E, Bork P. A genome-wide survey of human pseudogenes. Genome Res 2003, 13(12):2559-2567. 10.1101/gr.1455503, 403797, 14656963.
34. Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet 2009, 18(R1):R1-8. 10.1093/hmg/ddp011, 19297395.
35. Ionita-Laza I, Rogers AJ, Lange C, Raby BA, Lee C. Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics 2009, 93(1):22-26. 10.1016/j.ygeno.2008.08.012, 2631358, 18822366.
36. Lanktree M, Hegele RA. Copy number variation in metabolic phenotypes. Cytogenet Genome Res 2008, 123(1-4):169-175. 10.1159/000184705, 19287152.
37. McCarroll SA. Extending genome-wide association studies to copy-number variation. Hum Mol Genet 2008, 17(R2):R135-142. 10.1093/hmg/ddn282, 18852202.
38. Ptacek T, Li X, Kelley JM, Edberg JC. Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res 2008, 123(1-4):142-147. 10.1159/000184701, 2826785, 19287148.
39. Schaschl H, Aitman TJ, Vyse TJ. Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol 2009, 156(1):12-16. 10.1111/j.1365-2249.2008.03865.x, 19220326.
40. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008, 40(12):1413-1415. 10.1038/ng.259, 18978789.
41. Castle JC, Zhang C, Shah JK, Kulkarni AV, Kalsotra A, Cooper TA, Johnson JM. Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 2008, 40(12):1416-1425. 10.1038/ng.264, 18978788.
42. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456(7221):470-476. 10.1038/nature07509, 2593745, 18978772.
43. Eddy SR. Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2001, 2(12):919-929. 10.1038/35103511, 11733745.
44. Greve B, Hoffmann P, Vonthein R, Kun J, Lell B, Mycko MP, Selmaj KW, Berger K, Weissert R, Kremsner PG. NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. Malar J 2008, 7:251. 10.1186/1475-2875-7-251, 2635379, 19077231.
45. Harbord M, Hankin A, Bloom S, Mitchison H. Association between p47phox pseudogenes and inflammatory bowel disease. Blood 2003, 101(8):3337. 10.1182/blood-2002-10-3060, 12672696.
46. Zafari AM, Davidoff MN, Austin H, Valppu L, Cotsonis G, Lassegue B, Griendling KK. The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal 2002, 4(4):675-680. 10.1089/15230860260220184, 12230880.
47. Song Q, Cole JW, O'Connell JR, Stine OC, Gallagher M, Giles WH, Mitchell BD, Wozniak MA, Stern BJ, Sorkin JD, et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet 2006, 15(16):2468-2478. 10.1093/hmg/ddl169, 1634802, 16835261.
48. Song Q, Chao J, Chao L. DNA polymorphisms in the 5'-flanking region of the human tissue kallikrein gene. Hum Genet 1997, 99(6):727-734.